SoftBank-backed Neumora Therapeutics aims to raise up to $265m in US IPO

SoftBank-backed Neumora Therapeutics aims to raise up to $265m in US IPO

FILE PHOTO: The logo of SoftBank Group Corp is displayed at SoftBank World 2017 conference in Tokyo, Japan, July 20, 2017. REUTERS/Issei Kato

11 September, 2023

Amgen Neumora Therapeutics Softbank

Printed by Unregistered user on Wed, 13 Aug 2025 12:18:28 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

SoftBank's Arm looking to price IPO at top of range or above

SoftBank backs Stack AV, an autonomous trucking startup from Argo AI founders

Read more from World

AI startup Perplexity makes $34.5b takoever bid for Google’s Chrome

Advent to buy US-listed Israeli insurance software firm Sapiens for $2.5b